Commentary |

Searching for the Chicken's Egg in Transporter Gene Polymorphisms

Gregory A. Ordway, PhD
Arch Gen Psychiatry. 2000;57(8):739-740. doi:10.1001/archpsyc.57.8.739.
Text Size: A A A
Published online


THE ARTICLE by Mann and coworkers1 demonstrates, with a respectably large sample size, the association of major depression and suicide with low levels of serotonin transporter (5-HTT) binding in the prefrontal cortex. This extends these authors' previous demonstration of low levels of 5-HTT binding in prefrontal cortex from those who had committed suicide reported in a smaller sample size.2 Furthermore, the authors demonstrate, for the first time, that the anatomy of 5-HTT loss in the prefrontal cortex of subjects with major depression is more widespread than that found in those who commit suicide. The recent identification of a polymorphism in the promoter region of the human 5-HTT gene3 (5-HTTLPR) and the demonstration that the short promoter form has lower activity4 led these authors to logically examine the possible association of reduced 5-HTT in depression and suicide with the short-form (less active) 5-HTTLPR. As cited in their article, there is considerable controversy over whether this promoter polymorphism is associated with affective disorders. The findings of Mann and coworkers provide little evidence supporting a role of the less active short 5-HTTLPR in mood disorders. Their observations also suggest that low levels of 5-HTT binding found in major depression and suicide are not associated with a preponderance of the short 5-HTTLPR.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 3

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles